<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37268603</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets.</ArticleTitle><Pagination><StartPage>1019</StartPage><EndPage>1027</EndPage><MedlinePgn>1019-1027</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231182203</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aims to provide updated data on the incidence and prevalence of systemic lupus erythematosus (SLE) in New Zealand and to examine the difference between ethnic groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We identified the SLE cases from the national administrative datasets. The date of first identification of SLE was the earliest date of a related inpatient event or the earliest date of a related outpatient event. The crude incidence and prevalence of SLE in 2010-2021 were estimated by gender, age group and ethnicity. The WHO (World Health Organization) age-standardised rate (ASR) of incidence and prevalence of SLE was calculated, after stratifying the cases by ethnicity and gender.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The average ASR of incidence and prevalence of SLE in 2010-2021 was 2.1 and 42.1 per 100,000 people in New Zealand. The average ASR of incidence for women was 3.4 per 100,000 for women and 0.6 for men. It was highest for Pacific women (9.8), followed by Asian women (5.3) and M&#x101;ori women (3.6), and was lowest for Europeans/Others (2.1). The average ASR of prevalence was 65.2 per 100,000 for women and 8.5 for men. It was highest for Pacific women (176.2), followed by M&#x101;ori women (83.7) and Asian women (72.2), and was lowest for Europeans/Others (48.5). The ASR of prevalence of SLE has been increasing slightly over time: from 60.2 in 2010 to 66.1 per 100,000 in 2021 for women and from 7.6 in 2010 to 8.8 per 100,000 in 2021 for men.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The incidence and prevalence of SLE in New Zealand were comparable to the rates in European countries. Pacific people had the highest incidence and prevalence of SLE, more than three times the rates for Europeans/others. The high incidence of SLE in M&#x101;ori and Asian people also has implications for the future as these populations increase as a proportion to the total population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lao</LastName><ForeName>Chunhuan</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2319-8916</Identifier><AffiliationInfo><Affiliation>Medical Research Centre, The University of Waikato, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3717</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Douglas</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Waikato Hospital, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabindranath</LastName><ForeName>Kannaiyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Renal Unit, Waikato Hospital, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Dantzig</LastName><ForeName>Philippa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rheumatology Department, Waikato Hospital, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3718</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foxall</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Te Huataki Waiora - School of Health, The University of Waikato, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3717</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aporosa</LastName><ForeName>Apo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Psychology, The University of Waikato, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3717</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrenson</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Research Centre, The University of Waikato, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3717</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Strategy and Funding, Waikato Hospital, Hamilton, New Zealand.</Affiliation><Identifier Source="RINGGOLD">3718</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095284" MajorTopicYN="N">Maori People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095188" MajorTopicYN="N">Pacific Island People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">ethnic difference</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">lupus</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>22</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37268603</ArticleId><ArticleId IdType="pmc">PMC10333972</ArticleId><ArticleId IdType="doi">10.1177/09612033231182203</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kewalramani R, Singh AK. Immunopathogenesis of lupus and lupus nephritis: recent insights. Current Opinion in Nephrology and Hypertension 2002; 11: 273&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera R, Khamashta MA, Font J, et al.Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003; 82: 299&#x2013;308. DOI: 10.1097/01.md.0000091181.93122.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000091181.93122.55</ArticleId><ArticleId IdType="pubmed">14530779</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, et al.Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677&#x2013;2686. DOI: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber MRW, Drenkard C, Falasinnu T, et al.Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 2021; 17: 515&#x2013;532. DOI: 10.1038/s41584-021-00668-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00668-1</ArticleId><ArticleId IdType="pmc">PMC8982275</ArticleId><ArticleId IdType="pubmed">34345022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W.The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 2017; 56: 1945&#x2013;1961. DOI: 10.1093/rheumatology/kex260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kex260</ArticleId><ArticleId IdType="pubmed">28968809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan HJ, Song X, Johnson BH, et al.Healthcare utilization and costs of systemic lupus erythematosus in Medicaid. Biomed Res Int 2013; 2013: 110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591216</ArticleId><ArticleId IdType="pubmed">23484162</ArticleId></ArticleIdList></Reference><Reference><Citation>Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus 2001; 10: 439&#x2013;444. DOI: 10.1191/096120301678646191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120301678646191</ArticleId><ArticleId IdType="pubmed">11434580</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Parton H, Wang L, et al.Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the centers for disease control and prevention national lupus registries. Arthritis Rheumatol 2021; 73: 991&#x2013;996. DOI: 10.1002/art.41632.20210423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41632.20210423</ArticleId><ArticleId IdType="pmc">PMC8169527</ArticleId><ArticleId IdType="pubmed">33474834</ArticleId></ArticleIdList></Reference><Reference><Citation>Concannon A, Rudge S, Yan J, Reed P.The incidence, diagnostic clinical manifestations and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island children: the Starship experience (2000-2010). Lupus 2013; 22: 1156&#x2013;1161. DOI: 10.1177/0961203313503051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313503051</ArticleId><ArticleId IdType="pubmed">24003079</ArticleId></ArticleIdList></Reference><Reference><Citation>Burling F, Ng J, Thein H, et al.Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Lupus 2007; 16: 830&#x2013;837. DOI: 10.1177/0961203307080225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307080225</ArticleId><ArticleId IdType="pubmed">17895308</ArticleId></ArticleIdList></Reference><Reference><Citation>Otter SJ, Kumar S, Gow P, et al.Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey. J Foot Ankle Res 2016; 9: 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4802627</ArticleId><ArticleId IdType="pubmed">27006702</ArticleId></ArticleIdList></Reference><Reference><Citation>Otter SJ, Rohan M, Davies KA, et al.Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort. J Foot Ankle Res 2017; 10: 33. DOI: 10.1186/s13047-017-0217-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13047-017-0217-2</ArticleId><ArticleId IdType="pmc">PMC5530459</ArticleId><ArticleId IdType="pubmed">28770006</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett P, Thornley S, Scragg R. Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus 2016; 25: 1497&#x2013;1502. DOI: 10.1177/0961203316651745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316651745</ArticleId><ArticleId IdType="pubmed">27235700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart HH, Grigor RR, Caughey DE. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis 1983; 42: 529&#x2013;532. DOI: 10.1136/ard.42.5.529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.42.5.529</ArticleId><ArticleId IdType="pmc">PMC1001290</ArticleId><ArticleId IdType="pubmed">6625702</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics New Zealand . 2018 Census ethnic group summaries, Statistics New Zealand; 2020. https://www.stats.govt.nz/tools/2018-census-ethnic-group-summaries/. (accessed 26 May 2023).</Citation></Reference><Reference><Citation>Atkinson J, Salmond C, Crampton P. NZDep2018 Index of deprivation, final research Report, December 2020 . Wellington: University of Otago, 2019.</Citation></Reference><Reference><Citation>Statistics New Zealand . Age and sex by ethnic group for census night population counts, 2006, 2013, and 2018 Censuses . Wellington, New Zealand: Statistics New Zealand, 2023.</Citation></Reference><Reference><Citation>Leong PY, Huang JY, Chiou JY, Bai YC, Wei JCC.The prevalence and incidence of systemic lupus erythematosus in Taiwan: a nationwide population-based study. Sci Rep 2021; 11: 5631. DOI: 10.1038/s41598-021-84957-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84957-5</ArticleId><ArticleId IdType="pmc">PMC7952694</ArticleId><ArticleId IdType="pubmed">33707552</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Gong T, Peng Y, Nieman KM, Gilbertson DT.Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009-2016 US Medicare population. Lupus 2020; 29: 15&#x2013;26. DOI: 10.1177/0961203319888691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319888691</ArticleId><ArticleId IdType="pubmed">31726936</ArticleId></ArticleIdList></Reference><Reference><Citation>Basta F, Fasola F, Triantafyllias K, Schwarting A.Systemic lupus erythematosus (SLE) therapy: the old and the New. Rheumatol Ther 2020; 7: 433&#x2013;446. DOI: 10.1007/s40744-020-00212-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-020-00212-9</ArticleId><ArticleId IdType="pmc">PMC7410873</ArticleId><ArticleId IdType="pubmed">32488652</ArticleId></ArticleIdList></Reference><Reference><Citation>Yacoub Wasef SZ. Gender differences in systemic lupus erythematosus. Gend Med 2004; 1: 12&#x2013;17. DOI: 10.1016/s1550-8579(04)80006-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1550-8579(04)80006-8</ArticleId><ArticleId IdType="pubmed">16115579</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol 2012; 2012: 604892&#x2013;20120529. DOI: 10.1155/2012/604892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/604892</ArticleId><ArticleId IdType="pmc">PMC3368358</ArticleId><ArticleId IdType="pubmed">22690240</ArticleId></ArticleIdList></Reference><Reference><Citation>America LFo . Is lupus genetic? https://www.lupus.org/resources/your-genes-and-lupus#:&#x223c;:text=Thereisnoknowncauseforlupus%2Cbut,alllikelycontributetothedevelopmentoflupus</Citation></Reference><Reference><Citation>Ministry of Health . Pacific people&#x2019;s health, 2021, https://www.health.govt.nz/our-work/populations/pacific-health/pacific-peoples-health (accessed 13 March 2023).</Citation></Reference><Reference><Citation>Bengtsson AA, Rylander L, Hagmar L, et al.Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 2002; 41: 563&#x2013;571. DOI: 10.1093/rheumatology/41.5.563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/41.5.563</ArticleId><ArticleId IdType="pubmed">12011382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae EH, Lim SY, Han KD, et al.Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study. Korean J Intern Med 2020; 35: 652&#x2013;661. DOI: 10.3904/kjim.2018.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2018.303</ArticleId><ArticleId IdType="pmc">PMC7214355</ArticleId><ArticleId IdType="pubmed">31212409</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud L, Fagot JP, Mathian A, et al.Prevalence and incidence of systemic lupus erythematosus in France: a 2010 nation-wide population-based study. Autoimmun Rev 2014; 13: 1082-1089. DOI: 10.1016/j.autrev.2014.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.08.034</ArticleId><ArticleId IdType="pubmed">25172239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki LT, Feldman CH, Liu J, et al.Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 2012; 64: 2669&#x2013;2676. DOI: 10.1002/art.34472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34472</ArticleId><ArticleId IdType="pmc">PMC3564552</ArticleId><ArticleId IdType="pubmed">22847366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju JH, Yoon SH, Kang KY, et al.Prevalence of systemic lupus erythematosus in South Korea: an administrative database study. J Epidemiol 2014; 24: 295&#x2013;303. DOI: 10.2188/jea.je20120204.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je20120204</ArticleId><ArticleId IdType="pmc">PMC4074634</ArticleId><ArticleId IdType="pubmed">24857955</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatoye F, Gebrye T, Svenson LW. Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada. Rheumatol Int 2018; 38: 1721&#x2013;1726. DOI: 10.1007/s00296-018-4091-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-018-4091-4</ArticleId><ArticleId IdType="pmc">PMC6105153</ArticleId><ArticleId IdType="pubmed">29987494</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725. DOI: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>